Indegene

As pharma companies aim to streamline operations and scale globally, Global Capability Centers (GCCs) are becoming key drivers of success. But scaling pharma commercialization services and achieving excellence across domain-heavy functions like commercial, medical, and scientific services isn't without its challenges. Andy Faulkner, Naveen Gullapalli, Pedro F. LOPEZ, and Uday Bose delved into the success stories offering valuable insights into the opportunities and challenges in expanding domain-heavy functions at the Indegene Digital Summit. https://lnkd.in/fReGrkb #FutureReadyHealthcare

We're thrilled to share that Jack Mycka and Bill Lobb will be representing Indegene at BIO-Europe #BioEurope2024 from November 4-6 in Stockholm, Sweden! This premier #lifesciences event is the perfect place to explore cutting-edge advancements, foster meaningful collaborations, and discuss the future of healthcare. If you're attending, don't miss the chance to connect with Jack and William to explore collaboration opportunities in pricing, reimbursement, and market access strategies. Let’s work together to drive innovation and push the boundaries of healthcare!  Drop a comment below if you'll be there too or send us a message to set up a meeting! #FutureReadyHealthcare

In conversation with our SVP Peter Marchesini at Indegene Digital Summit 2024, Adele Gulfo, CEO, Biopharma Commercial Unit, Sumitomo Pharma America, Inc., offered us a ringside view of her highly successful pharma commercialization playbook. She spoke about why aligning on a strong value proposition with payers and stakeholders earlier in the process, is integral to a brand’s success. She emphasized why there’s no excuse for not understanding the patient’s journey, given the kind of data available. Adele also touched upon how pharma companies can drive deeper engagement with HCPs, patients and payers via a hybrid (personal + virtual) approach, and, what it takes to build a truly patient-centered organization. Read Vibha Ravi’s story in Scrip (Citeline) for the key highlights. https://lnkd.in/dyM9v-Xj   #FutureReadyHealthcare

It's time to transform how you access knowledge and make smarter decisions. Discover how a high-precision, context-aware Generative AI Semantic Search solution can unlock actionable information faster, tailored to your specific needs, while ensuring compliance with global pharma regulations. Dive into the latest insights from Mihir Pandit and Keyur Prabhu in our new blog post! https://lnkd.in/dfPvPXMP   #FutureReadyHealthcare

We had a powerful session on how #GenerativeAI is reshaping PV—boosting efficiency and accuracy at the 6th Indegene Digital Summit. Our experts shared real-world examples, tackled challenges, and gave a glimpse into the future of AI in PV. A big thank you to our panelists Anand Ramanathan PMP, Clapton Dias, Dr Fatima Bhayat and session moderator Nikesh Shah for their valuable insights! Continue the conversation in the comments below—what are your thoughts on AI in PV? https://lnkd.in/fReGrkb #FutureReadyHealthcare

Christopher Corsico (GSK), Darren Weston (Johnson & Johnson), Christoph Koenen (Bayer) and Badhri Srinivasan (Novartis) came together at Indegene Digital Summit 2024 to discuss AI’s transformative role across the entire clinical development value chain. They agreed on why a robust data infrastructure foundation is a prerequisite for success, and how a cautious approach to using GenAI in newer areas like Cart-T therapy is necessary. Read Anju Ghangurde’s story in Scrip (Citeline) for more. https://lnkd.in/d8_JQfwx #FutureReadyHealthcare

Anil Matai, Director General, Organisation of Pharmaceutical Producers of India (OPPI), hosted our CTO Tarun Mathur, for a digital knowledge exchange session for OPPI’s members. Tarun shared insights on how GenAI is enabling pharma leaders to reimagine business processes, enhance HCP engagement and improve patient outcomes. He also highlighted which specific GenAI bets are pharma CXOs prioritizing, and why a balanced approach to adopting/scaling GenAI is the best way to succeed. Check out the video for more! https://lnkd.in/dFghC3Nf #FutureReadyHealthcare

Join Dr Siva Kumar BUDDHA at World Drug Safety Congress Americas, for a powerful session on how AI-driven causality assessments are transforming automation in pharmacovigilance. His session will shed light on how cutting-edge AI techniques improve safety signal detection and streamline risk management, ultimately enhancing patient safety. #FutureReadyHealthcare

Discover how to determine the ROI for GenAI in #Pharmacovigilance at our session with Nikesh Shah and Dr Siva Kumar BUDDHA at the World Drug Safety Congress Americas #WDSCAmericas 2024.     The session will cover complexities, solutions, and strategies for securing funding and demonstrating value.    #FutureReadyHealthcare

From leading Pfizer Oncology to shaping global strategies, Suneet Varma had a wealth of knowledge to share. At Indegene Digital Summit 2024, he offered groundbreaking insights on leadership, culture, and innovation. Discover how his visionary approach can embrace learning agility, advance digital maturity, and enhance innovation. Check out the highlights here - https://lnkd.in/fReGrkb #FutureReadyHealthcare